AOD 9604
Modified GH fragment, 5mg vial
From
£30
IN STOCKWeight management
Weight management
Weight Management Compounds: Research Context and Sourcing Notes.
Compounds in this category appear across published metabolic-research literature, often involving GLP-1 and dual-agonist pathways. Each batch is HPLC tested by an independent third-party laboratory and a Certificate of Analysis is available to download from every product page.
Weight management compounds
4 of 4
View
Retatrutide
Triple GIP/GLP-1/glucagon agonist, 50mg vial
From
£155
BEST SELLERWeight management
Tesamorelin
Stabilised GHRH analogue, 10mg vial
From
£55
IN STOCKWeight management
Tirzepatide
Dual GIP/GLP-1 analogue, 60mg vial
From
£145
BEST SELLERWeight management
Adjacent research
FORM Peptides catalogues compounds across five research categories. Researchers studying weight management compounds often cross-reference the hormonal/longevity, cellular regeneration and skin health listings. Every compound on this site is supplied with batch-level HPLC documentation and a research-use-only label.
Supplied for research purposes only. Not for human consumption. FORM Peptides does not provide dosage or consumption advice.
Programmatic supply
Running a larger programme?
Bulk and recurring research supply, custom batch documentation, and institutional invoicing are available on request.
Supplied for research purposes only. Not for human consumption. FORM Peptides does not provide dosage or consumption advice.